Join to View Full Profile
3400 Spruce St1 Maloney BuildingPhiladelphia, PA 19104
Phone+1 215-662-3957
Dr. Roy-Ghanta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Allergy and Immunology, 2005 - 2007
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine/Pediatrics, 2001 - 2005
Northeast Ohio Medical UniversityClass of 2001
Certifications & Licensure
PA State Medical License 2007 - 2026
MI State Medical License Active through 2014
American Board of Allergy and Immunology Allergy & Immunology
American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- DREAMM-11, Part 2: Japanese phase I trial of belantamab mafodotin combination therapies in relapsed/refractory multiple myeloma.Kazutaka Sunami, Shinsuke Iida, Nobuhiro Tsukada, Taku Fujii, Hitomi Kato
International Journal of Hematology. 2025-02-01 - Results from Arm A of Phase 1/2 DREAMM-6 trial: belantamab mafodotin with lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma.Rakesh Popat, Bradley Augustson, Mercedes Gironella, Cindy Lee, Paul Cannell
Blood Cancer Journal. 2024-10-21 - 21 citationsBelantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma.Vania Hungria, Pawel Robak, Marek Hus, Vera Zherebtsova, Christopher Ward
The New England Journal of Medicine. 2024-08-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
